Page last updated: 2024-08-23

pravastatin and adenosine

pravastatin has been researched along with adenosine in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (75.00)	29.6817
2010's	2 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Chou, TF; Lee, TM; Su, SF; Tsai, CH	1
Hurme, M; Ilveskoski, E; Janatuinen, T; Knuuti, J; Laaksonen, R; Lehtimäki, T; Luomala, M; Mattila, K; Nuutila, P; Saikku, P; Vesalainen, R	1
Janatuinen, T; Knuuti, J; Laakso, J; Laaksonen, R; Lehtimäki, T; Nuutila, P; Raitakari, OT; Vesalainen, R	1
Bolli, R; Jneid, H; Leessar, M	1
Ilveskoski, E; Janatuinen, T; Karhunen, PJ; Knuuti, J; Laaksonen, R; Laippala, P; Lehtimäki, T; Nuutila, P; Vesalainen, R	1

Reviews

2 review(s) available for pravastatin and adenosine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Cardiac preconditioning during percutaneous coronary interventions. Cardiovascular drugs and therapy, 2005, Volume: 19, Issue:3 Topics: Adenosine; Angioplasty, Balloon, Coronary; Bradykinin; Humans; Ischemic Preconditioning, Myocardial; Nicorandil; Nitroglycerin; Pravastatin	2005

Trials

4 trial(s) available for pravastatin and adenosine

Article	Year
Effect of pravastatin on myocardial protection during coronary angioplasty and the role of adenosine. The American journal of cardiology, 2001, Nov-15, Volume: 88, Issue:10 Topics: Adenosine; Aminophylline; Analysis of Variance; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Coronary Disease; Electrocardiography; Female; Hemodynamics; Humans; Hyperlipidemias; Lactates; Male; Middle Aged; Myocardial Ischemia; Pravastatin	2001
Interleukin-1B genotype modulates the improvement of coronary artery reactivity by lipid-lowering therapy with pravastatin: a placebo-controlled positron emission tomography study in young healthy men. Pharmacogenetics, 2003, Volume: 13, Issue:10 Topics: Adenosine; Adult; Anticholesteremic Agents; C-Reactive Protein; Cholesterol, LDL; Coronary Circulation; Double-Blind Method; Follow-Up Studies; Genotype; Humans; Interleukin-1; Lipid Metabolism; Male; Myocardium; Placebos; Polymorphism, Genetic; Pravastatin; Tomography, Emission-Computed	2003
Plasma asymmetric dimethylarginine modifies the effect of pravastatin on myocardial blood flow in young adults. Vascular medicine (London, England), 2003, Volume: 8, Issue:3 Topics: Adenosine; Adult; Anticholesteremic Agents; Arginine; Blood Flow Velocity; Coronary Circulation; Double-Blind Method; Enzyme Inhibitors; Humans; Hyperemia; Male; Nitric Oxide Synthase; Pravastatin; Regional Blood Flow; Tomography, Emission-Computed	2003
Improvement of myocardial blood flow by lipid-lowering therapy with pravastatin is modulated by apolipoprotein E genotype. Scandinavian journal of clinical and laboratory investigation, 2007, Volume: 67, Issue:7 Topics: Adenosine; Adult; Analysis of Variance; Apolipoproteins E; C-Reactive Protein; Cholesterol; Cholesterol, LDL; Coronary Circulation; Double-Blind Method; Gene Frequency; Genotype; Humans; Male; Polymorphism, Genetic; Positron-Emission Tomography; Pravastatin; Treatment Outcome	2007

Other Studies

2 other study(ies) available for pravastatin and adenosine

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010

Article

Year

Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.

Current drug discovery technologies, 2004, Volume: 1, Issue:4

Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004

Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.

Chemical research in toxicology, 2010, Volume: 23, Issue:1

Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010